LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $200,000 | -29.6% | 2,014 | -19.1% | 0.01% | -27.3% |
| Q2 2019 | $284,000 | -78.7% | 2,488 | -48.7% | 0.01% | -80.4% |
| Q3 2018 | $1,331,000 | +29.5% | 4,850 | -2.2% | 0.06% | +14.3% |
| Q2 2018 | $1,028,000 | +38.0% | 4,961 | +10.0% | 0.05% | +145.0% |
| Q1 2018 | $745,000 | +25.4% | 4,511 | +4.0% | 0.02% | +66.7% |
| Q4 2017 | $594,000 | -4.2% | 4,337 | -4.8% | 0.01% | -7.7% |
| Q3 2017 | $620,000 | +24.0% | 4,556 | +10.7% | 0.01% | +18.2% |
| Q2 2017 | $500,000 | – | 4,116 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |